The estimated Net Worth of Glynn Wilson is at least $1.28 Milión dollars as of 26 July 2021. Dr Wilson owns over 50,000 units of Jupiter Wellness stock worth over $1,140,000 and over the last 14 years he sold JUPW stock worth over $139,500. In addition, he makes $4,000 as Chief Science Officer & Director at Jupiter Wellness.
Dr has made over 1 trades of the Jupiter Wellness stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 50,000 units of JUPW stock worth $139,500 on 26 July 2021.
The largest trade he's ever made was selling 50,000 units of Jupiter Wellness stock on 26 July 2021 worth over $139,500. On average, Dr trades about 3,846 units every 0 days since 2011. As of 26 July 2021 he still owns at least 750,000 units of Jupiter Wellness stock.
You can see the complete history of Dr Wilson stock trades at the bottom of the page.
Dr. Glynn Wilson Ph.D. is the Chief Science Officer & Director at Jupiter Wellness.
As the Chief Science Officer & Director of Jupiter Wellness, the total compensation of Dr D at Jupiter Wellness is $4,000. There are 2 executives at Jupiter Wellness getting paid more, with Brian Scott John having the highest compensation of $223,583.
Dr D is 74, he's been the Chief Science Officer & Director of Jupiter Wellness since . There are no older and 4 younger executives at Jupiter Wellness.
Glynn's mailing address filed with the SEC is C/O JUPITER WELLNESS, INC 1061 E., INDIANTOWN ROAD,SUITE 110, JUPITER, FL, 33477.
Over the last 4 years, insiders at Jupiter Wellness have traded over $1,509,066 worth of Jupiter Wellness stock and bought 1,922,782 units worth $235,784 . The most active insiders traders include John Gulyas, Brian John a Skender Fani. On average, Jupiter Wellness executives and independent directors trade stock every 77 days with the average trade being worth of $374,478. The most recent stock trade was executed by John Gulyas on 31 August 2023, trading 1,666,666 units of JUPW stock currently worth $2,533,332.
Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products. The company's clinical pipeline includes CaniDermRX (JW-100), a novel topical formulation containing CBD and aspartame for the treatment of eczema, dermatitis, and actinic keratosis; JW-101, a prescription product for the treatment of burns; and JW-200, a non-prescription lotion/lip balm for the treatment of symptoms of cold sores. It also manufactures, distributes, and markets a line of consumer products, such as CBD-infused sunscreen under the CaniSun brand; CBD-infused skin care lotion under the CaniSkin brand; and products for the dermatological treatments of pain and inflammation under the CaniDermRX brand. The company was formerly known as CBD Brands, Inc. Jupiter Wellness, Inc. was incorporated in 2018 and is headquartered in Jupiter, Florida.
Jupiter Wellness executives and other stock owners filed with the SEC include: